ORGENESIS INC. Deferred Tax Assets, in Process Research and Development
ORGENESIS INC. had Deferred Tax Assets, in Process Research and Development of $4.47 million as of 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-03-26
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $4.47M.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $3.93M.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $1.89M.
- 2021-12-31: Deferred Tax Assets, in Process Research and Development $1.27M.
| Period end | Deferred Tax Assets, in Process Research and Development | Deferred Tax Assets, in Process Research and Development as first filed |
|---|---|---|
| 2024-12-31 | $4.47M 10-K · filed 2026-03-26 | |
| 2023-12-31 | $3.93M 10-K · filed 2026-03-26 | |
| 2022-12-31 | $1.89M 10-K · filed 2024-04-15 | |
| 2021-12-31 | $1.27M 10-K · filed 2023-03-22 | |
| 2020-12-31 | $1.68M 10-K · filed 2022-03-30 | |
| 2019-12-31 | $1.36M 10-K · filed 2021-03-09 | $2.17M 10-K · filed 2020-03-09 |
| 2018-12-31 | $3.06M 10-K · filed 2020-03-09 | |
| 2018-11-30 | $2.92M 10-K · filed 2019-02-13 | |
| 2017-11-30 | $1.06M 10-K · filed 2019-02-13 |